N-Butyldeoxynojirimycin, film (dried in situ)

Descriptions

Application

N-Butyldeoxynojirimycin has been used:in the inhibition of glycolipid synthesis in neuroblastoma cellsin the inhibition the ceramide-specific glycosyltransferase in hepatocytesin the inhibition of ?-glucosidase (GBA2) using fluorescence- activity assay in human embryonic kidney (HEK293) cells.

Biochem/physiol Actions

N-Butyldeoxynojirimycin is an inhibitor of glucosyltransferase and ?-glucosidases. N-Butyldeoxynojirimycin, also known as misglustat, reduces glycolipid levels by substrate reduction therapy (SRT) and is effectively used for the treatment of glycosphingolipid lysosomal storage disorder, Gaucher disease.

α-glucosidase Inhibitor

General description

N-Butyldeoxynojirimycin is an alkylated product of imino sugar deoxynojirimycin.

Packaging

1, 5 mg in glass bottle

Specifications

No detailed specifications are available for this product.

Downloads

There are no downloads for this product.

Code	Description	Quality Level	InChI key	InChI	Manufacturer	Solubility	Form	Assay	Price
3586655	N-Butyldeoxynojirimycin, film (dried in situ)	200	UQRORFVVSGFNRO-UTINFBMNSA-N	1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1	SIGMA-ALDRICH	water: 9.80-10.20 mg/mL, clear, colorless	film (dried in situ)	≥98% (TLC)	You need to be logged in to see prices.
3586656	N-Butyldeoxynojirimycin, film (dried in situ)	200	UQRORFVVSGFNRO-UTINFBMNSA-N	1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1	SIGMA-ALDRICH	water: 9.80-10.20 mg/mL, clear, colorless	film (dried in situ)	≥98% (TLC)	You need to be logged in to see prices.